EP 0946182 A1 19991006 - 17-g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
Title (en)
17-g(a)-DIHYDROEQUILENIN FOR USE AS A MEDICAL ANTIOXIDANT
Title (de)
17ALPHA-DIHYDROEQUILENIN ZUR VERWENDUNG ALS MEDIZINISCHER ANTIOXYDANT
Title (fr)
17-g(a)-DIHYDROEQUILENINE A UTILISER COMME ANTIOXYDANT MEDICAL
Publication
Application
Priority
- US 9722155 W 19971205
- US 76263496 A 19961209
Abstract (en)
[origin: WO9825627A1] This invention provides a method of using 17 alpha -dihydroequilenin or a pharmaceutically acceptable salt of 17 alpha -dihydroequilenin-3-sulfate ester as an antioxidant.
IPC 1-7
IPC 8 full level
A61K 31/565 (2006.01); A61K 31/575 (2006.01); A61P 19/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 35/00 (2006.01); A61P 39/06 (2006.01)
IPC 8 main group level
A61K (2006.01)
CPC (source: EP KR)
A61K 31/565 (2013.01 - KR); A61K 31/5685 (2013.01 - EP); A61P 19/00 (2017.12 - EP); A61P 25/28 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 35/00 (2017.12 - EP); A61P 39/06 (2017.12 - EP)
Citation (search report)
See references of WO 9825627A1
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE
DOCDB simple family (publication)
WO 9825627 A1 19980618; AR 010336 A1 20000607; AU 5464498 A 19980703; AU 743519 B2 20020131; BR 9714382 A 20000516; CA 2272089 A1 19980618; CN 1239890 A 19991229; EP 0946182 A1 19991006; HU P0000570 A2 20001028; HU P0000570 A3 20001228; IL 130069 A0 20000229; JP 2001506629 A 20010522; KR 20000069346 A 20001125; NZ 336341 A 20020201; ZA 9711053 B 19990609
DOCDB simple family (application)
US 9722155 W 19971205; AR P970105739 A 19971205; AU 5464498 A 19971205; BR 9714382 A 19971205; CA 2272089 A 19971205; CN 97180446 A 19971205; EP 97948610 A 19971205; HU P0000570 A 19971205; IL 13006997 A 19971205; JP 52680598 A 19971205; KR 19997005048 A 19990607; NZ 33634197 A 19971205; ZA 9711053 A 19971209